UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

THE IMPACT OF EPILEPSY ON THE OVERALL DEVELOPMENT OF CHILDREN WITH AUTISM SPECTRUM DISORDERS

Type of Article

In the Section

Index UDK:

Abstract

15—30 % of children with autistic spectrum disorders (ASD) are diagnosed with epilepsy during their lifetime, and 20—39 % of children with ASD have neurophysiological phenomena specific to epilepsy on the EEG. The presence of epilepsy and specific epileptic activity on the EEG may impair the prognosis of cognitive development, motor functions and social functioning in children with ASD.

Objective: to investigate the features of the clinical course of ASD in preschool children with epileptic seizures and specific epileptic activity on the EEG.

During 2016—2021 170 children with ASD were selected and included in the study, a control group of 65 people and a main group of 105 people were formed. Patients in the main group are divided into two subgroups: IA children with autism and epilepsy — 35 people; IВ children with autism and specific epileptic changes on the human EEG — 70.

ASD and epilepsy have a mutually burdensome course. Seizures occurring at an early age are more resistant to the use of antiepileptic therapy, these children have lower indicators of social functioning and psychophysical development.

Children with ASD and comorbid epileptic seizures tend to accumulate delays in the development of perceptual clusters, gross motor skills, visual-motor coordination, speech development, and cognitive skills. There are 4 variants of the clinical course of ASD: a variant with general developmental delay (accumulation of a lag from the expected developmental trajectory when assessing PER-R), a variant with a plateau of developmental delay, a variant with early onset of symptoms when assessing ADI-R and ADOS between the ages of 12 and 24 months; variant with late manifestation of autistic symptoms. In the IB subgroup cases of mental retardation predominate, compared to the control group and the IA subgroup, which indicates the accumulation of additional cases of seizure-free forms of epileptic encephalopathies, encephalopathies development, encephalopathies with epileptic disintegration.

Pages

References

  1. Autism spectrum disorder: classification, diagnosis and therapy / Sharma S. R., Gonda X., Tarazi F. I. [et al.] // Pharmacology & therapeutics. 2018. Vol. 190. P. 91—104. DOI: https://doi.org/10.1016/j.pharmthera.2018.05.007.
  2. Autism spectrum disorder / Campisi L., Imran N., Nazeer A. [et al.] // British medical bulletin. 2018. Vol.127(1). DOI: https://doi.org/10.1093/bmb/ldy026.
  3. The changing epidemiology of autism spectrum disorders / Lyall K., Croen L., Daniels J. [et al.] // Annual review of public health. 2017. Vol. P.  81—102. DOI: https://doi.org/10.1146/annurev-publhealth-031816-044318.
  4. Epilepsy and EEG Abnormalities in Children with Autism Spectrum Disorders / Sharma V., Saini A. G., Malhi, P. [et al.] // Indian journal of 2021. P.  1—8. DOI: https://doi.org/10.1007/s12098-021-03928-w.
  5. Martsenkovskyi, I. A. Protyepileptychni preparaty ta inshi zasoby likuvannia epilepsii u ditei z rozladamy spektra autyzmu. Ukrainskyi visnyk psykhonevrolohii. 2014. T. 22, vyp. 3 (80). S. 121–126. URI: http://nbuv.gov.ua/UJRN/Uvp_2014_22_3_29.
  6. Epilepsy and autism severity: a study of 6,975 children / Ewen   B. [et  al.]  // Autism Research. 2019. Vol.  12, No.  8. Р. 1251—1259. DOI: https://doi.org/10.1002/aur.2132.
  7. Prevalence and risk factors for autism spectrum disorder in epilepsy: a systematic review and meta‐analysis / Strasser L., Downes M., Kung, J. [et al.] // Developmental Medicine & Child Neurology. 2018. Vol. 60(1). P 19—29. DOI: https://doi.org/10.1111/dmcn.13598.
  8. Features of autism spectrum disorder (ASD) in childhood epilepsy: a population‐based study  / Reilly C., Atkinson  , Das K. B. [et al.] // Epilepsy & Behavior. 2015. Vol. 42. P. 86–92. DOI: https://doi.org/10.1016/j.yebeh.2014.11.014.
  9. Frequent association of autism spectrum disorder in patients with childhood onset epilepsy / Matsuo M., Maeda T., Sasaki K. [et al.] // Brain Development. 2010. Vol.32. P. 759–763. DOI: https://doi.org/10.1016/j.braindev.2010.05.005.
  10. EEG endophenotypes in autism spectrum disorder / Capal J. K., Carosella C., Corbin E. [et al.] // Epilepsy & Behavior. 2018. Vol. 88. P. 341—348. DOI: https://doi.org/10.1016/j.yebeh.2018.09.036.
  11. Jacob J. Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders / J. Jacob // Epilepsia. 2016. Vol. 57, No. 2. P. 182—193. DOI: https://doi.org/10.1111/epi.13272.
  12. Nomi J. S. Face processing in autism spectrum disorders: from brain regions to brain networks / J. S. Nomi, L. Q. Uddin // Neuropsychologia. 2015. Vol. 71. P. 201—216. DOI: https://doi.org/10.1016/j.neuropsychologia.2015.03.029.
  13. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders / D. S. Mandell, K. H. Morales, S. C. Marcus [et al.] // Pediatrics. 2008. Vol. 121. P. 441—448. DOI: https://doi.org/10.1542/peds.2007-0984.
  14. Kwan P. Neuropsychological effects of epilepsy and antiepileptic drugs / P. Kwan, M.    Brodie  // Lancet. 2001. Vol.  357. P.  216—222. DOI: https://doi.org/10.1016/s0140-6736(00)03600-x.
  15. Besag, F. M. Epilepsy in patients with autism: links, risks and treatment challenges / F. M. Besag  // Neuropsychiatric disease and treatment. 2018. Vol. 14. P. 1—10. DOI: https://doi.org/10.2147/ndt.s120509.